AAOS 2026: No Effect of Extended Oral TXA After Total Knee Arthroplasty on Pain and Range of Motion .
No Effects of Extended Oral Tranexamic Acid following Total Knee Arthroplasty on Postoperative Pain and Range of Motion: A Randomized Controlled Trial
48 patients undergoing total knee arthroplasty were randomized to receive extended oral tranexamic acid (TXA) during the first 3 days post-operation (n=24) or a placebo (n=24). The primary outcome of interest was pain scores, measured during the first 3 months post-operation. Secondary outcomes of interest included range of motion, ambulation status, and opioid consumption. Results revealed no significant differences between the two groups in all outcomes, suggesting that extended TXA use provides no additional benefit in this context.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
